The antibacterial activity of allyl derivatives of thiosemicarbazide, N1-thiocarbamylamidrazone, 1,2,4-triazole-5-thione, 1,3,4-(thiadiazol-2-yl) amine and derivatives of bicyclic systems: 1,2,4-triazole[3,4-b]1,3-thiazine, 1,2,4-triazole[3,2-b]1,3-thiazine, 1,3,4-thiadiazole[3,2-a]pyrimidine, thiazolo[2,3-c][1,2,4]triazole

Authors

  • Leokadia Strzemecka Chair and Department of Organic Chemistry, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author
  • Urszula Kosikowska Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author
  • Anna Malm Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Poland Author

DOI:

https://doi.org/10.12923/j.2084-980X/25.2/a.09

Keywords:

allyl derivatives of thiosemicarbazide, N1-thiocarbamyl-N3-phenyl-amidrazones, 1,2,4-triazole-5-thione, 1,3,4-thiadiazol-2-yl-amine and bicyclic systems, 1,2,4-triazole[3,4-b]1,3-thiazine, thiazolo[2,3-c][1,2,4]triazole, the antimicrobial activity

Abstract

The 1-acyl(aroil)-4-(allyl)cinnamyl-thiosemicarbazides (1-9), N1-allyl(cinnamyl)-thiocarbamyl-N3-phenyl-amidrazones (10-12), allyl derivatives of 1,2,4-triazole-5-thione (13-23), 1,3,4-(thiadiazol-2-yl) amine (24-29), derivatives of bicyclic systems: 1,2,4-triazole[3,4-b]1,3-thiazine (30-34), 1,2,4-triazole[3,2-b]1,3-thiazine (35), 1,3,4-thiadiazole[3,2-a]pyrimidine (36, 37), hydrazide derivatives of substituted benzoic acid (38, 39), 3,4-disubstituted-3,4,5,6-tetrahydropyrimidine-2-thione-(2-thiol) (40) and thiazolo[2,3-c][1,2,4]triazole (41-43) were screened for their in vitro activity against the reference strains of Gram-positive and Gram-negative bacteria. The compounds (11, 12, 20, 37) showed moderate activity against Gram-positive bacterial species with MIC = 31.25-62.5 µg/mL and may be of value for searching new derivatives showing better antimicrobial activity. The structure-activity relationship has been discussed.

References

1. Abdel-Rahman H.M., Hussein M.A.: Synthesis of β-hydroxypropanoic acid derivatives as potential antiinflammatory, analgesic and antimicrobial agents. Arch. Pharm. Chem. Life Sci., 339, 378, 2006.

2. Abdel-Wahab B.F., Abdel-Aziz H.A., Ahmed E.M.: Synthesis and antimicrobial evaluation of some 1,3-tiazole, 1,3,4-thiadiazole, 1,2,4-triazole and 1,2,4-triazolo[3,4-b]1,3,4-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety. Monatsh. Chem., 140, 601, 2009.

3. Bourgeois I. et al: Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative Staphylococci. Antimicrob. Agents Chemother., 51(2): 740, 2007.

4. Demirbas A. et al: Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities. Eur. J. Med. Chem., 44, 2896, 2009.

5. Demirbas N., Ugurluoglu R. and Demirbas A.: Synthesis of 3-alkyl(aryl-4-alkylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-ones and 3-alkyl-4-alkylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones as antitumor agents. Bioorg. Med. Chem., 10, 3717, 2002.

6. Galabov A.S., Galabov B.S., Neykova N.A.: Structure-activity relationship of diphenylthiourea antivirals. J. Med. Chem., 23, 1048, 1980.

7. Kadi A.A. et al: Synthesis, antimicrobial and antiinflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles. Eur. J. Med. Chem., 42, 235, 2007.

8. Kerimow I. et al: Synthesis, antifungal and antioxidant screening of some novel benzimidazole derivatives. J. Enzym. Inhibit. and Med. Chem., 22, 696, 2007.

9. Keshk E.M. et al: Synthesis and reactions of some new quinoline thiosemicarbazide derivatives of potential biological activity. Phosphorus Sulfur Silicon Relat. Elem., 183, 1323, 2008.

10. Küçükgüzel İ. et al.: Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/antiHIV and antituberculosis agents. Eur. J. Med. Chem., 43, 381, 2008.

11. Olsson M.H.M., Mavri J., Warshel A.: Transition state theory can be used in studies of enzyme catalysis: lessons from simulations of tunneling and dynamical effects in lipoxygenase and other systems. Phil.Trans. R. Soc., B 361, 1417, 2006.

12. Rostom S.A.F. et al: Azole antimicrobial pharmacophpre-based tetrazoles: synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents. Bioorg. Med. Chem., 17, 2410, 2009.

13. Rollas S., Büyüktimkin S., Çevikbas A.: N-[4-(3H-1,3,4-Oxadiazoline-2-thion-5- yl)phenyl]-N’-substituted thioureas: synthesis and antimicrobial activities. Arch. Pharm., 324,189, 1991.

14. Salgın-Gökşen U. et al: 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-antiinflammatory and antimicrobial activities. Bioorg. Med. Chem., 15, 5738, 2007.

15. Shafiee A.: Synthesis and in vitro antimicrobial evaluation of 5-(1-methyl-5-nitro-2-imidazolyl)-4H-1,2,4-triazoles. Arch. Pharm. Pharm. Med. Chem., 10, 495, 2002.

16. Solak N., Rollas S.: Synthesis and antituberculosis activity of 2-(aryl/alkylamino)-5-(4-aminophenyl)-1,3,4-thiadiazoles and their Schiff bases. Arkivoc (xii), 173, 2006.

17. Strzemecka L.: Cyclization reaction of 1,4-disubstituted thiosemicarbazides. Part II. Pol. J. Chem., 63, 117, 1989.

18. Strzemecka L.: Cyclization of N1-(cinnamyl-thiocarbamyl) amidrazones. Part II. Pol. J. Chem., 64, 557, 1990.

19. Strzemecka L.: Synthesis of 3,6-disubstituted 5,6-dihydrothiazolo-[2,3-c][1,2,4]triazole system. Pol. J. Chem., 57, 567, 1983.

20. Strzemecka L., Otto T.: Cyclization reaction of 1,4-disubstituted thiosemicarbazides. Part I. Pol. J. Chem., 62, 757, 1988.

21. Strzemecka L.: Cyclization of N1-(cinnamyl-thiocarbamyl) amidrazones. Part I. Pol. J. Chem., 64, 157, 1990.

22. Strzemecka L.: Tautomerism of 1,3,4-thiadiazole. Part I. Ann. UMCS, Sectio AA, L/LI (7), 81, 1995/1996.

23. Strzemecka L.. Syntheses of allyl derivatives of 1,2,4-triazole and 1,3,4-thiadiazole. Pol. J. Chem., 57, 561, 1983.

24. Strzemecka L: Synthesis of 5H-3,7-disubstituted 6,7-dihydro-1,2,4-triazole[3,4-b]1,3-thiazine and 7H-2,5-disubstituted-5,6-dihydro-1,2,4-triazole[3,2-b]1,3-thiazine systems. Pol. J. Chem., 57, 881, 1983.

25. Strzemecka L.: Tautomerism of 1,3,4-thiadiazole. Part II. Ann. UMCS, Sectio AA, LIV/LV (21), 363, 1999/2000.

26. Strzemecka L.: The electronic structure of the nitrogen atoms of allyl-(5-pyridin-2-yl-[1,3,4]-thiadiazol-2-yl)-amine. Int. J. Mol. Sci., 7, 231, 2006.

27. Strzemecka L.: The antiHIV, antitumor activity of allyl derivatives of 1,2,4-triazole-5-thione, 1,3,4-thiadiazol-2-ylamine and derivatives of bicyclic systems: 1,2,4-triazole[3,4-b]1,3-thiazine, 1,2,4-triazole[3,2-b]1,3-thiazine, thiazolo[2,3-c][1,2,4]triazole. Ann. UMCS, Sectio DDD, (in press)

28. White E.L. et al: 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J. Antimicrob. Chemother., 50, 111, 2002.

Downloads

Published

2012-04-01

How to Cite

Strzemecka, L., Kosikowska, U., & Malm, A. (2012). The antibacterial activity of allyl derivatives of thiosemicarbazide, N1-thiocarbamylamidrazone, 1,2,4-triazole-5-thione, 1,3,4-(thiadiazol-2-yl) amine and derivatives of bicyclic systems: 1,2,4-triazole[3,4-b]1,3-thiazine, 1,2,4-triazole[3,2-b]1,3-thiazine, 1,3,4-thiadiazole[3,2-a]pyrimidine, thiazolo[2,3-c][1,2,4]triazole. Current Issues in Pharmacy and Medical Sciences, 25(2), 153-158. https://doi.org/10.12923/j.2084-980X/25.2/a.09